I-MAB

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Each filer's latest filing for 44975P103 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Everest Medicines Ltd 13D	16.1%	42,524,716	13D	8/5/2025 Event 8/5/2025
CBC Investment I-Mab Ltd 13D/A	11.5%	30,499,709	13D/A	2/3/2026 Event 1/29/2026
CBC Investment I-Mab Limited	4.4%	11,784,164
IBC Investment Seven Limited	1.4%	3,641,554
CBC Spvii Limited	2.1%	5,574,560
C-Bridge II Investment Ten Limited	0.9%	2,369,546
Nova Aqua Limited	2.7%	7,129,885
C-Bridge Healthcare Fund II, L.P.	5.3%	14,153,710
C-Bridge Healthcare Fund GP II, L.P.	5.3%	14,153,710
C-Bridge Capital GP, Ltd.	8.8%	23,369,824
I-Bridge Healthcare Fund, L.P.	3.5%	9,216,114
I-Bridge Healthcare GP, L.P.	3.5%	9,216,114
I-Bridge Capital GP, Ltd.	3.5%	9,216,114
Wei Fu	11.5%	30,499,709
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
HHLR Advisors, Ltd. 13D/A	4.9%	13,295,306	13D/A	11/5/2026 Event 11/5/2026
HHLR Advisors, Ltd.	4.9%	13,295,306
Hillhouse Investment Management, Ltd.	4.9%	13,295,306

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	11	1.56 M	$2.14 M	$0
2026 Q2	50	24.7 M	$48.1 M	$67.7 k
2026 Q1	49	29.3 M	$72.1 M	$47.2 k
2025 Q4	60	33.2 M	$132 M	$244 k
2025 Q3	46	29.8 M	$113 M	$254 k
2025 Q2	34	9.40 M	$22.7 M	$24.7 k
2025 Q1	32	8.99 M	$7.41 M	$27.4 k
2024 Q4	30	11.9 M	$10.1 M	$12.3 k
2024 Q3	31	14.2 M	$17.6 M	$77.1 k
2024 Q2	42	15.2 M	$25.4 M	$8.18 k
2024 Q1	44	12.2 M	$22.7 M	$28.6 k
2023 Q4	49	13.0 M	$24.7 M	$7.41 k
2023 Q3	50	15.3 M	$20.1 M	$27.9 k
2023 Q2	51	18.7 M	$55.9 M	$56.5 k
2023 Q1	57	20.7 M	$71.6 M	$138 k
2022 Q4	74	25.4 M	$106 M	$141 k
2022 Q3	78	30.8 M	$123 M	$111 k
2022 Q2	105	40.8 M	$459 M	$3.02 M
2022 Q1	130	40.8 M	$666 M	$8.39 M
2021 Q4	142	39.2 M	$1.86 B	$3.21 M
2021 Q3	151	36.1 M	$2.61 B	$8.05 M
2021 Q2	143	28.3 M	$2.38 B	$8.51 M
2021 Q1	82	23.3 M	$1.13 B	$291 k
2020 Q4	67	14.8 M	$699 M	$0
2020 Q3	49	9.53 M	$448 M	$0
2020 Q2	21	4.68 M	$139 M	$0
2020 Q1	17	4.68 M	$60.8 M	$0